Relation Between Smoking and Disability Progression in Iranian Multiple Sclerosis Patients: A Case‑Control Study

Fereshteh Ashtari, Mahtab Sardashti Birjandi, Iman Adibi, Awat Feizi, Arshia Ghalamkari, Nafiseh Toghianifar

Abstract


Background: To compare characteristics of patients with multiple sclerosis (MS) between cigarette smokers and non‑smokers. Methods: A case‑control study was performed on patients registered in the Kashani MS center from April 2019 to April 2020 in Isfahan, Iran. In total, 136 smoker patients and 220 non‑smokers participated in the study and completed the questionnaire. Results: The frequency of male gender in the smoker group was significantly higher than in the non‑smokers (64.7% vs. 15%, P < 0.001). The mean age at MS onset was 31.5 ± 9.60 years among cigarette smokers and 29.7 ± 9.47 years among non‑smokers (P = 0.794). Furthermore, 80% of cigarette smokers and 64% of non‑smokers had at least one relapse per year (ARR ≥1, P < 0.001). The Expanded Disability Status Scale (EDSS) of more than 4.5 was significantly higher in smokers (26.5% vs. 18%, P = 0.023). There was a relation between an EDSS of more than 4.5 and an interval between smoking initiation and disease onset (P = 0.004). Long duration of smoking was associated with a higher disability scale (16.4 ± 9.5 vs. 9.8 ± 7.3, P = 0.008). Men smoked for a longer period of time before developing MS than women (9.24 ± 10.07 vs. 4.47 ± 7.61, P = 0.002). The average daily cigarette consumption was 7.74 ± 6.65 in women and 10.84 ± 9.44 in men (P = 0.024). Duration of smoking before the onset of the disease was 4.47 ± 7.61 years in women and 9.24 ± 10.07 in men (P = 0.002). Conclusions: Our data suggest that there is a possible relationship between disability score and the duration of smoking before the onset of MS. It also revealed that the duration of smoking can affect the progression of the disease. Further studies are suggested to confirm these findings.

International Journal of Preventive Medicine 16():12, February 2025. | DOI: 10.4103/ijpvm.ijpvm_336_23

Corresponding Author: Prof. Fereshteh Ashtari

E‑mail: f_ashtari@med.mui.ac.ir

You can also search for this author in: PubMed Google Scholar


Keywords


Cigarette, multiple sclerosis, smoking

Full Text:

PDF

References


Dobson R, Giovannoni G. Multiple sclerosis–A review. Eur J Neurol 2019;26:27 40.

Sahraian MA, Sahebkar M, Dehghani R, Derakhshan Jazari M, Kazami Moghaddam V, Kouchaki E. Multiple sclerosis A disease on a dramatically rising trend in Iran: Review of possible reasons. Iran J Neurol 2017;16:34 40.

Kamińska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis etiology and diagnostic potential. Postepy Hig Med Dosw (Online) 2017;71:551 63.

Marrodan M, Alessandro L, Farez MF, Correale J. The role of infections in multiple sclerosis. Mult Scler 2019;25:891 901.

Ashtari F, Toghianifar N, Zarkesh Esfahani SH, Mansourian M. High dose Vitamin D intake and quality of life in relapsing remitting multiple sclerosis: A randomized, double blind, placebo controlled clinical trial. Neurolog Res 2016;38:888 92.

Jasielski P, Piędel F, Rocka A, Petit V, Rejdak K. Smoking as a risk factor of onset and relapse of multiple sclerosis—A review. Neurol Neurochir Pol 2020;54:243 51.

Manouchehrinia A, Huang J, Hillert J, Alfredsson L, Olsson T, Kockum I, et al. Smoking attributable risk in multiple sclerosis. Front Immunol 2022:13:840158.

Kvistad S, Myhr K M, Holmøy T, Benth JŠ, Løken Amsrud KI, Wergeland S, et al. No association between tobacco use and disease activity in multiple sclerosis. Neurol Neuroimmunol Neuroinflammat 2016;3:e260.

Weiland TJ, Hadgkiss EJ, Jelinek GA, Pereira NG, Marck CH, van der Meer DM. The association of alcohol consumption and smoking with quality of life, disability, and disease activity in an international sample of people with multiple sclerosis. J Neurol Sci 2014;336:211 9.

Tanasescu R, Constantinescu CS, Tench CR, Manouchehrinia A. Smoking cessation and the reduction of disability progression in Multiple Sclerosis: A cohort study. Nicotine Tob Res 2018;20:589 95.

Wang Z, Xie J, Wu C, Xiao G. Correlation between smoking and passive smoking with multiple sclerosis and the underlying molecular mechanisms. Med Sci Monit 2019;25:893.

Khodadost M, Maajani K, Noroozi A, Motevalian SA, Naserbakht M, Sarvi F, et al. Prevalence of cigarette smoking among college students in Iran: An updated systematic review and meta analysis of observational studies. Med J Islam Repub Iran 2020;34:165.

Abdollahpour I, Nedjat S, Sahraian MA, Mansournia MA, Otahal P, van der Mei I. Waterpipe smoking associated with multiple sclerosis: A population based incident case control study. Mult Scler 2017;23:1328 35.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 Revisions of the McDonald criteria. Lancet Neurol 2018;17:162 73.

Manouchehrinia A, Tench CR, Maxted J, Bibani RH, Britton J, Constantinescu CS. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 2013;136:2298 304.

Rosso M, Chitnis T. Association between cigarette smoking and multiple sclerosis: A review. JAMA Neurol 2020;77:245 53.

Hernán MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 2005;128:1461 5.

Ivashynka A, Copetti M, Naldi P, D’Alfonso S, Leone MA. The impact of lifetime alcohol and cigarette smoking loads on multiple sclerosis severity. Front Neurol 2019;10:866.

Koch M, van Harten A, Uyttenboogaart M, De Keyser J. Cigarette smoking and progression in multiple sclerosis. Neurology 2007;69:1515 20.

Vandebergh M, Goris A. Smoking and multiple sclerosis risk: A Mendelian randomization study. J Neurol 2020;267:3083 91.

Hedström AK, Olsson T, Alfredsson L. Cotinine as a measure of smoking in observational studies of multiple sclerosis. Mult Scler 2021;27:1293 6.

Healy BC, Ali EN, Guttmann CR, Chitnis T, Glanz BI, Buckle G, et al. Smoking and disease progression in multiple sclerosis. Arch Neurol 2009;66:858 64.